Genetic modification of donor hepatocytes improves therapeutic efficacy for hemophilia B in mice

Cell Transplantation

Volumn 19, Issue 9, 2010, Pages 1169-1180

  Wu, Yao Ming ^a   Kao, Chung Yang ^b   Huang, Yu Jen ^a   Yu, I Shing ^b   Lee, Hsuan Shu ^a   Lai, Hong Shiee ^a   Lee, Po Huang ^a   Lin, Chia Ni ^b   Lin, Shu Wha ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Bioengineered coagulation factor ix; Genetically engineered donor cells; Hemophilia B; Hepatocyte transplantation

Indexed keywords

BLOOD CLOTTING FACTOR 9;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOENGINEERING; BLOOD CLOTTING; CELL ISOLATION; CELL THERAPY; CELL TRANSPLANTATION; CONTROLLED STUDY; HEMOPHILIA B; HEMOSTASIS; HUMAN; LIVER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; THROMBUS;

ANIMALS; CELL TRANSPLANTATION; DISEASE MODELS, ANIMAL; FACTOR IX; GENE EXPRESSION REGULATION; HEMOPHILIA B; HEPATOCYTES; HUMANS; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; TISSUE ENGINEERING;

MUS;

EID: 78649823411     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368910X503398     Document Type: Article

References (56)

1. Adams, R. M.; Wang, M.; Crane, A. M.; Brown, B.; Darlington, G. J.; Ledley, F. D. Effective cryopreservation and long-term storage of primary human hepatocytes with recovery of viability, differentiation, and replicative potential. Cell Transplant. 4:579-586; 1995.
2. Baccarani, U.; Adani, G. L.; Sainz, M.; Donini, A.; Risaliti, A.; Bresadola, F. Human hepatocyte transplantation for acute liver failure: State of the art and analysis of cell sources. Transplant. Proc. 37:2702-2704; 2005.
3. Bolton-Maggs, P. H.; Pasi, K. J. Haemophilias A and B. Lancet 361:1801-1809; 2003.
4. Brunetti-Pierri, N.; Grove, N. C.; Zuo, Y.; Edwards, R.; Palmer, D.; Cerullo, V.; Teruya, J.; Ng, P. Bioengineered factor IX molecules with increased catalytic activity improve the therapeutic index of gene therapy vectors for hemophilia B. Hum. Gene Ther. 20:479-485; 2009.
5. Bumgardner, G. L.; Li, J.; Heininger, M.; Ferguson, R. M.; Orosz, C. G. In vivo immunogenicity of purified allogeneic hepatocytes in a murine hepatocyte transplant model. Transplantation 65:47-52; 1998.
6. Cai, J.; Ito, M.; Nagata, H.; Westerman, K. A.; Lafleur, D.; Chowdhury, J. R.; Leboulch, P.; Fox, I. J. Treatment of liver failure in rats with end-stage cirrhosis by transplantation of immortalized hepatocytes. Hepatology 36: 386-394; 2002.
7. Cerullo, V.; Seiler, M. P.; Mane, V.; Cela, R.; Clarke, C.; Kaufman, R. J.; Pipe, S. W.; Lee, B. Correction of murine hemophilia A and immunological differences of factor VIII variants delivered by helper-dependent adenoviral vectors. Mol. Ther. 15:2080-2087; 2007.
8. Chang, J.; Jin, J.; Lollar, P.; Bode, W.; Brandstetter, H.; Hamaguchi, N.; Straight, D. L.; Stafford, D. W. Changing residue 338 in human factor IX from arginine to alanine causes an increase in catalytic activity. J. Biol. Chem. 273: 12089-12094; 1998.
9. Chang, J. Y.; Monroe, D. M.; Stafford, D. W.; Brinkhous, K. M.; Roberts, H. R. Replacing the first epidermal growth factor-like domain of factor IX with that of factor VII enhances activity in vitro and in canine hemophilia B. J. Clin. Invest. 100:886-892; 1997.
10. Chang, Y. J.; Wu, H. L.; Hamaguchi, N.; Hsu, Y. C.; Lin, S. W. Identification of functionally important residues of the epidermal growth factor-2 domain of factor IX by alanine-scanning mutagenesis. Residues Asn(89)-Gly(93) are critical for binding factor VIIIa. J. Biol. Chem. 277: 25393-25399; 2002.
11. Dhawan, A.; Mitry, R. R.; Hughes, R. D.; Lehec, S.; Terry, C.; Bansal, S.; Arya, R.; Wade, J. J.; Verma, A.; Heaton, N. D.; Rela, M.; Mieli-Vergani, G. Hepatocyte transplantation for inherited factor VII deficiency. Transplantation 78:1812-1814; 2004.
12. Donahue, S. M.; Otto, C. M. Thromboelastography: A tool for measuring hypercoagulability, hypocoagulability, and fibrinolysis. J. Vet. Emerg. Crit. Care 15:9-16; 2005.
13. Donsante, A.; Miller, D. G.; Li, Y.; Vogler, C.; Brunt, E. M.; Russell, D. W.; Sands, M. S. AAV vector integration sites in mouse hepatocellular carcinoma. Science 317: 477; 2007.
14. Fox, I. J.; Chowdhury, J. R.; Kaufman, S. S.; Goertzen, T. C.; Chowdhury, N. R.; Warkentin, P. I.; Dorko, K.; Sauter, B. V.; Strom, S. C. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N. Engl. J. Med. 338:1422-1426; 1998.
15. Greenwood, R.; Wang, B.; Midkiff, K.; White, 2nd, G. C.; Lin, H. F.; Frelinger, J. A. Identification of T-cell epitopes in clotting factor IX and lack of tolerance in inbred mice. J. Thromb. Haemost. 1:95-102; 2003.
16. Grossman, M.; Rader, D. J.; Muller, D. W.; Kolansky, D. M.; Kozarsky, K.; Clark, 3rd, B. J.; Stein, E. A.; Lupien, P. J.; Brewer, Jr., H. B.; Raper, S. E.; Wilson, J. M. A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia. Nat. Med. 1:1148-1154; 1995.
17. Groth, C. G.; Arborgh, B.; Bjorken, C.; Sundberg, B.; Lundgren, G. Correction of hyperbilirubinemia in the glucuronyltransferase-deficient rat by intraportal hepatocyte transplantation. Transplant. Proc. 9:313-316; 1977.
18. Guha, C.; Parashar, B.; Deb, N. J.; Garg, M.; Gorla, G. R.; Singh, A.; Roy-Chowdhury, N.; Vikram, B.; Roy-Chowdhury, J. Normal hepatocytes correct serum bilirubin after repopulation of Gunn rat liver subjected to irradiation/partial resection. Hepatology 36:354-362; 2002.
19. Gupta, S.; Aragona, E.; Vemuru, R. P.; Bhargava, K. K.; Burk, R. D.; Chowdhury, J. R. Permanent engraftment and function of hepatocytes delivered to the liver: Implications for gene therapy and liver repopulation. Hepatology 14: 144-149; 1991.
20. Gupta, S.; Rajvanshi, P.; Sokhi, R.; Slehria, S.; Yam, A.; Kerr, A.; Novikoff, P. M. Entry and integration of transplanted hepatocytes in rat liver plates occur by disruption of hepatic sinusoidal endothelium. Hepatology 29:509-519; 1999.
21. Hacein-Bey-Abina, S.; von Kalle, C.; Schmidt, M.; Le Deist, F.; Wulffraat, N.; McIntyre, E.; Radford, I.; Villeval, J. L.; Fraser, C. C.; Cavazzana-Calvo, M.; Fischer, A. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 348:255-256; 2003.
22. Hanna, J.; Wernig, M.; Markoulaki, S.; Sun, C. W.; Meissner, A.; Cassady, J. P.; Beard, C.; Brambrink, T.; Wu, L. C.; Townes, T. M.; Jaenisch, R. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318:1920-1923; 2007.
23. Hoffman, R. Hematology: Basic principles and practice, 4th ed. Philadelphia, PA: Elsevier Churchill Livingstone; 2005.
24. Ito, M.; Ito, R.; Yoshihara, D.; Ikeno, M.; Kamiya, M.; Suzuki, N.; Horiguchi, A.; Nagata, H.; Yamamoto, T.; Kobayashi, N.; Fox, I. J.; Okazaki, T.; Miyakama, S. Immortalized hepatocytes using human artificial chromosome. Cell Transplant. 17:165-171; 2008.
25. Jin, D. Y.; Zhang, T. P.; Gui, T.; Stafford, D. W.; Monahan, P. E. Creation of a mouse expressing defective human factor IX. Blood 104:1733-1739; 2004.
26. Kaji, K.; Norrby, K.; Paca, A.; Mileikovsky, M.; Mohseni, P.; Woltjen, K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458:771-775; 2009.
27. Kaufman, R. J. Post-translational modifications required for coagulation factor secretion and function. Thromb. Haemost. 79:1068-1079; 1998.
28. Knolle, P. A.; Schmitt, E.; Jin, S.; Germann, T.; Duchmann, R.; Hegenbarth, S.; Gerken, G.; Lohse, A. W. Induction of cytokine production in naive CD4(+) T cells by antigen-presenting murine liver sinusoidal endothelial cells but failure to induce differentiation toward Th1 cells. Gastroenterology 116:1428-1440; 1999.
29. Limmer, A.; Ohl, J.; Kurts, C.; Ljunggren, H. G.; Reiss, Y.; Groettrup, M.; Momburg, F.; Arnold, B.; Knolle, P. A. Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nat. Med. 6:1348-1354; 2000.
30. Lin, C. N.; Kao, C. Y.; Miao, C. H.; Hamaguchi, N.; Wu, H. L.; Shi, G. Y.; Liu, Y. L.; High, K. A.; Lin, S. W. Generation of a novel factor IX with augmented clotting activities in vitro and in vivo. J. Thromb. Haemost. 8: 1773-1783; 2010.
31. Lin, H. F.; Maeda, N.; Smithies, O.; Straight, D. L.; Stafford, D. W. A coagulation factor IX-deficient mouse model for human hemophilia B. Blood 90:3962-3966; 1997.
32. Manno, C. S.; Pierce, G. F.; Arruda, V. R.; Glader, B.; Ragni, M.; Rasko, J. J.; Ozelo, M. C.; Hoots, K.; Blatt, P.; Konkle, B.; Dake, M.; Kaye, R.; Razavi, M.; Zajko, A.; Zehnder, J.; Rustagi, P. K.; Nakai, H.; Chew, A.; Leonard, D.; Wright, J. F.; Lessard, R. R.; Sommer, J. M.; Tigges, M.; Sabatino, D.; Luk, A.; Jiang, H.; Mingozzi, F.; Couto, L.; Ertl, H. C.; High, K. A.; Kay, M. A. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat. Med. 12:342-347; 2006.
33. Margaritis, P.; Arruda, V. R.; Aljamali, M.; Camire, R. M.; Schlachterman, A.; High, K. A. Novel therapeutic approach for hemophilia using gene delivery of an engineered secreted activated Factor VII. J. Clin. Invest. 113: 1025-1031; 2004.
34. Marshall, E. Gene therapy. Second child in French trial is found to have leukemia. Science 299:320; 2003.
35. Matas, A. J.; Sutherland, D. E.; Steffes, M. W.; Mauer, S. M.; Sowe, A.; Simmons, R. L.; Najarian, J. S. Hepatocellular transplantation for metabolic deficiencies: Decrease of plasms bilirubin in Gunn rats. Science 192:892-894; 1976.
36. Mingozzi, F.; Liu, Y. L.; Dobrzynski, E.; Kaufhold, A.; Liu, J. H.; Wang, Y.; Arruda, V. R.; High, K. A.; Herzog, R. W. Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer. J. Clin. Invest. 111:1347-1356; 2003.
37. Mingozzi, F.; Maus, M. V.; Hui, D. J.; Sabatino, D. E.; Murphy, S. L.; Rasko, J. E.; Ragni, M. V.; Manno, C. S.; Sommer, J.; Jiang, H.; Pierce, G. F.; Ertl, H. C.; High, K. A. CD8(+) T-cell responses to adeno-associated virus capsid in humans. Nat. Med. 13:419-422; 2007.
38. Miyamoto, Y.; Enosawa, S.; Takeuchi, T.; Takezawa, T. Cryopreservation in situ of cell monolayers on collagen vitrigel membrane culture substrata: Ready-to-use preparation of primary hepatocytes and ES cells. Cell Transplant. 18:619-626; 2009.
39. Muraca, M.; Gerunda, G.; Neri, D.; Vilei, M. T.; Granato, A.; Feltracco, P.; Meroni, M.; Giron, G.; Burlina, A. B. Hepatocyte transplantation as a treatment for glycogen storage disease type 1a. Lancet 359:317-318; 2002.
40. Okita, K.; Nakagawa, M.; Hyenjong, H.; Ichisaka, T.; Yamanaka, S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 322:949-953; 2008.
41. Park, I. H.; Zhao, R.; West, J. A.; Yabuuchi, A.; Huo, H.; Ince, T. A.; Lerou, P. H.; Lensch, M. W.; Daley, G. Q. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451:141-146; 2008.
42. Ponder, K. P.; Gupta, S.; Leland, F.; Darlington, G.; Finegold, M.; DeMayo, J.; Ledley, F. D.; Chowdhury, J. R.; Woo, S. L. Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation. Proc. Natl. Acad. Sci. USA 88:1217-1221; 1991.
43. Raper, S. E.; Grossman, M.; Rader, D. J.; Thoene, J. G.; Clark, 3rd, B. J.; Kolansky, D. M.; Muller, D. W.; Wilson, J. M. Safety and feasibility of liver-directed ex vivo gene therapy for homozygous familial hypercholesterolemia. Ann. Surg. 223:116-126; 1996.
44. Rhim, J. S. Development of human cell lines from multiple organs. Ann. NY Acad. Sci. 919:16-25; 2000.
45. Schuettrumpf, J.; Herzog, R. W.; Schlachterman, A.; Kaufhold, A.; Stafford, D. W.; Arruda, V. R. Factor IX variants improve gene therapy efficacy for hemophilia B. Blood 105:2316-2323; 2005.
46. Simioni, P.; Tormene, D.; Tognin, G.; Gavasso, S.; Bulato, C.; Iacobelli, N. P.; Finn, J. D.; Spiezia, L.; Radu, C.; Arruda, V. R. X-linked thrombophilia with a mutant factor IX (factor IX Padua). N. Engl. J. Med. 361:1671-1675; 2009.
47. Song, Z.; Cai, J.; Liu, Y.; Zhao, D.; Yong, J.; Duo, S.; Song, X.; Guo, Y.; Zhao, Y.; Qin, H.; Yin, X.; Wu, C.; Che, J.; Lu, S.; Ding, M.; Deng, H. Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell Res. 19:1233-1242; 2009.
48. Takahashi, K.; Tanabe, K.; Ohnuki, M.; Narita, M.; Ichisaka, T.; Tomoda, K.; Yamanaka, S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872; 2007.
49. Tatsumi, K.; Ohashi, K.; Shima, M.; Nakajima, Y.; Okano, T.; Yoshioka, A. Therapeutic effects of hepatocyte transplantation on hemophilia B. Transplantation 86:167-170; 2008.
50. Tsuruga, Y.; Kiyono, T.; Matsushita, M.; Takahashi, T.; Kasai, H.; Matsumoto, S.; Todo, S. Establishment of immortalized human hepatocytes by introduction of HPV16 E6/E7 and hTERT as cell sources for liver cell-based therapy. Cell Transplant. 17:1083-1094; 2008.
51. van Hylckama Vlieg, A.; van der Linden, I. K.; Bertina, R. M.; Rosendaal, F. R. High levels of factor IX increase the risk of venous thrombosis. Blood 95:3678-3682; 2000.
52. Wu, Y. M.; Joseph, B.; Berishvili, E.; Kumaran, V.; Gupta, S. Hepatocyte transplantation and drug-induced perturbations in liver cell compartments. Hepatology 47: 279-287; 2008.
53. Wu, Y. M.; Joseph, B.; Gupta, S. Immunosuppression using the mTOR inhibition mechanism affects replacement of rat liver with transplanted cells. Hepatology 44:410-419; 2006.
54. Yu, C. H.; Chen, H. L.; Chen, Y. H.; Chang, M. F.; Chien, C. S.; Chang, M. H. Impaired hepatocyte regeneration in acute severe hepatic injury enhances effective repopulation by transplanted hepatocytes. Cell Transplant. 18: 1081-1092; 2009.
55. Yu, J.; Vodyanik, M. A.; Smuga-Otto, K.; Antosiewicz-Bourget, J.; Frane, J. L.; Tian, S.; Nie, J.; Jonsdottir, G. A.; Ruotti, V.; Stewart, R.; Slukvin, I. I.; Thomson, J. A. Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-1920; 2007.
56. Zou, J.; Maeder, M. L.; Mali, P.; Pruett-Miller, S. M.; Thibodeau-Beganny, S.; Chou, B. K.; Chen, G.; Ye, Z.; Park, I. H.; Daley, G. Q.; Porteus, M. H.; Joung, J. K.; Cheng, L. Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell 5:97-110; 2009.